Lipocine (LPCN) Misses Q1 EPS by 1c

Lipocine (NASDAQ: LPCN) reported Q1 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Bristow Group to acquire Berry Aviation for $105 million